Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia

Archivos Espanoles de Urologia

Volumn 54, Issue 2, 2001, Pages 191-196

  Türkeri, Levent N ^a,b   Özyürek, Mustafa ^a   Ersev, Deniz ^a   Akdaş, Atif ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Alpha adrenergic blockers; Apoptosis; Benign prostatic hyperplasia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; UROFLOWMETRY;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; APOPTOSIS; DOUBLE-BLIND METHOD; DOXAZOSIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; TIME FACTORS;

EID: 18844466908     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. DANESHGARI, F. and CRAWFORD, E.D.: "Benign prostatic disease. A growing challenge in the 1990's." Post Grad. Med., 93: 84, 1993.
2. BERRY, S.S.; COFFEY, D.S.; WALSH, P.C. et al.: "The development of human benign prostatic hyperplasia with age." J. Urol., 132: 474, 1984.
3. BARTSCH, G.; MULLER, H.R.; OBERHOLZER, M. et al.: "Light microscopic stereological analysis of the normal human prostate and of benign hyperplasia." J. Urol., 122: 487, 1979.
4. PRICE, D.T.; SCHWINN, D.A.; LOMASNEY, J.W. et al.: "Identification, quantification and localization of mRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate." J. Urol., 150: 546, 1993.
5. LEPOR, H.: "Terazosin in the treatment of benign prostatic hyperplasia." In: Textbook of Benign Prostatic Hyperplasia. R. Kirby, J.D. McConell, J.M. Fitzpatrick, C. Roehrborn, P. Boyle (eds.). Isis Medical Media, Oxford, 1996.
6. GAVRIELI, Y.; SHERMAN, Y.; BEN-SASSON, S.A.: "Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation." J. Cell B ol., 119: 493, 1992.
7. JARDIN, A.; BENSADOUN, H.; DELAUCHE-CAVALLIER, M. C. et al.: "Alfuzosin for treatment of benign prostatic hypertrophy." Lancet, 337: 1457, 1991.
8. LEPOR, H.; KNAPP-MALONEY, G.; SUNSHINE, H.: "A dose titration study evaluating terazosin, a selective once a day α-1 blocker for the treatment of benign prostatic hyperplasia." J. Urol., 144: 1393, 1990.
9. LEPOR, H.; KNAPP-MALONEY, G.: "Outcome assessment of terazosin for benign prostatic hyperplasia (BPH): 18 month follow-up." J. Urol., 145: 263A, 1991.
10. LITVAK, J.P.; BORKOWSKI, A.; JACOBS, S.C. et al.: "Induction of prostate apoptosis by doxazosin: targeting alpha 1 blockade in benign prostatic hyperplasia." J. Urol., 157: 1086A, 1997.